Shibata et al., [51] identified elevated expression levels of pChk1 (S317) and to a lesser extent pH2AX (S139) as being predictive of the sensitivity of breast cancer cell lines to the Chk1 inhibitor PF-477736. The gene discussed is CHEK1; the disease is breast carcinoma.